chr20-63361195-G-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000467563.3(CHRNA4):​n.110C>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.744 in 1,453,094 control chromosomes in the GnomAD database, including 407,618 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.68 ( 35383 hom., cov: 26)
Exomes 𝑓: 0.75 ( 372235 hom. )

Consequence

CHRNA4
ENST00000467563.3 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.228

Publications

10 publications found
Variant links:
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
CHRNA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 20-63361195-G-C is Benign according to our data. Variant chr20-63361195-G-C is described in ClinVar as Benign. ClinVar VariationId is 3255233.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.766 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNA4NM_000744.7 linkc.-30C>G 5_prime_UTR_variant Exon 1 of 6 ENST00000370263.9 NP_000735.1 P43681-1B4DK78Q59FV0
CHRNA4NR_046317.2 linkn.155C>G non_coding_transcript_exon_variant Exon 1 of 6
CHRNA4NM_001256573.2 linkc.-489C>G 5_prime_UTR_variant Exon 1 of 6 NP_001243502.1 P43681Q4VAQ3B4DK78Q59FV0
LOC100130587NR_110634.1 linkn.183-623G>C intron_variant Intron 1 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNA4ENST00000370263.9 linkc.-30C>G 5_prime_UTR_variant Exon 1 of 6 1 NM_000744.7 ENSP00000359285.4 P43681-1

Frequencies

GnomAD3 genomes
AF:
0.677
AC:
101428
AN:
149920
Hom.:
35357
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.525
Gnomad AMI
AF:
0.740
Gnomad AMR
AF:
0.747
Gnomad ASJ
AF:
0.738
Gnomad EAS
AF:
0.416
Gnomad SAS
AF:
0.581
Gnomad FIN
AF:
0.699
Gnomad MID
AF:
0.642
Gnomad NFE
AF:
0.772
Gnomad OTH
AF:
0.661
GnomAD2 exomes
AF:
0.707
AC:
52306
AN:
73954
AF XY:
0.698
show subpopulations
Gnomad AFR exome
AF:
0.525
Gnomad AMR exome
AF:
0.772
Gnomad ASJ exome
AF:
0.730
Gnomad EAS exome
AF:
0.391
Gnomad FIN exome
AF:
0.705
Gnomad NFE exome
AF:
0.770
Gnomad OTH exome
AF:
0.729
GnomAD4 exome
AF:
0.751
AC:
979257
AN:
1303076
Hom.:
372235
Cov.:
48
AF XY:
0.748
AC XY:
478862
AN XY:
640390
show subpopulations
African (AFR)
AF:
0.511
AC:
13464
AN:
26366
American (AMR)
AF:
0.766
AC:
19024
AN:
24840
Ashkenazi Jewish (ASJ)
AF:
0.722
AC:
16593
AN:
22970
East Asian (EAS)
AF:
0.432
AC:
12244
AN:
28326
South Asian (SAS)
AF:
0.599
AC:
42400
AN:
70782
European-Finnish (FIN)
AF:
0.713
AC:
23147
AN:
32480
Middle Eastern (MID)
AF:
0.677
AC:
2622
AN:
3874
European-Non Finnish (NFE)
AF:
0.780
AC:
810830
AN:
1039636
Other (OTH)
AF:
0.724
AC:
38933
AN:
53802
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
11608
23216
34825
46433
58041
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19804
39608
59412
79216
99020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.677
AC:
101490
AN:
150018
Hom.:
35383
Cov.:
26
AF XY:
0.674
AC XY:
49337
AN XY:
73218
show subpopulations
African (AFR)
AF:
0.525
AC:
21447
AN:
40884
American (AMR)
AF:
0.747
AC:
11350
AN:
15190
Ashkenazi Jewish (ASJ)
AF:
0.738
AC:
2544
AN:
3448
East Asian (EAS)
AF:
0.417
AC:
2021
AN:
4852
South Asian (SAS)
AF:
0.582
AC:
2778
AN:
4774
European-Finnish (FIN)
AF:
0.699
AC:
7252
AN:
10382
Middle Eastern (MID)
AF:
0.632
AC:
177
AN:
280
European-Non Finnish (NFE)
AF:
0.772
AC:
51875
AN:
67234
Other (OTH)
AF:
0.665
AC:
1384
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1446
2892
4337
5783
7229
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
792
1584
2376
3168
3960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.649
Hom.:
2154
Bravo
AF:
0.672

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 87% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 81. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
17
DANN
Benign
0.76
PhyloP100
-0.23
PromoterAI
0.024
Neutral
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6090387; hg19: chr20-61992547; COSMIC: COSV104427203; COSMIC: COSV104427203; API